Dag Nord • 1959 • Sørumsand • 16 roles • 10 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
D DA-NO HOLDING AS	Managing Director/CEO	-	18,764,889	60 % directly
E ENDOTECH AS	Managing Director/CEO	79,469,946	7,029,932	20.52 % indirectly
E ET INNOVASJON AS	Managing Director/CEO	-	940,822	14.46 % indirectly
N NEORESQ AS	Managing Director/CEO	200,000	46,542	10.58 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
D DA-NO HOLDING AS	Chairman	-	18,764,889	60 % directly
U UTHUSSETRA 9 AS	Board Member	-	-163,964	30 % indirectly
N NORDIC MEDICAL GROUP AS	Chairman	-	30,854,620	21.6 % indirectly
W WAMALINO GROUP AS	Board Member	6,538,491	39,210,419	21.6 % indirectly
E ENDOTECH INVEST AS	Board Member	-	24,729	21 % indirectly
E ENDOTECH AS	Board Member	79,469,946	7,029,932	20.52 % indirectly
E ET INNOVASJON AS	Board Member	-	940,822	14.46 % indirectly
N NDS SECURITY AS	Board Member	25,998,338	694,428	-
B BLAKER SAMFUNNSHUS BA	Deputy Chair	-	-	-
M MABSEMBALLASJE AS	Chairman	13,504,197	90,000	-
B BLAKER UNGDOMSLAG	Contact Person	-	-	-

Last update: Jul 26, 2024

Shares owned by Dag Nord

Name	Share class	Total operating income	Total equity	Share
D DA-NO HOLDING AS	B-aksjer Ordinære aksjer	0 0	18,764,889 18,764,889	10 % directly 60 % 50 % directly 60 %
U UTHUSSETRA 9 AS		0	-163,964	30 % indirectly
N NORDIC MEDICAL GROUP AS		0	30,854,620	21.6 % indirectly
W WAMALINO GROUP AS		6,538,491	39,210,419	21.6 % indirectly
E ENDOTECH INVEST AS		0	24,729	21 % indirectly
E ENDOTECH AS		79,469,946	7,029,932	20.52 % indirectly
E ET INNOVASJON AS		0	940,822	14.46 % indirectly
N NEORESQ AS		200,000	46,542	10.58 % indirectly
N NIKKIMED AS		0	15,551	5.4 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025